Cover Image
Market Research Report

Japan Contract Research Organization Market

Published by Frost & Sullivan Product code 337350
Published Content info 72 Pages
Delivery time: 1-2 business days
Price
Back to Top
Japan Contract Research Organization Market
Published: August 7, 2015 Content info: 72 Pages
Description

Aging Population and Liberal Regulations will Propel Clinical Trial Growth

This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from preclinical trials to post-marketing surveillance. It provides detailed information on support services such as central laboratory services, bioanalytics, and data management.

Table of Contents
Product Code: 9AB9-00-34-00-00

Table of Contents

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. CRO Market Size by Stage of Clinical Development
  • 4. Market Size Estimation Methodology
  • 5. Scope and Segmentation
  • 6. Key Questions this Study will Answer
  • 7. Total CRO Market Engineering Measurements
  • 8. CEO's Perspective
  • 9. Key Companies to Watch
  • 10. Key Companies to Watch (continued)

Market Overview

  • 1. Pharmaceutical Market Overview
  • 2. Pharmaceutical Market Overview (continued)
  • 3. Market Perspective

Clinical Trials Market Overview

  • 1. Clinical Trials Market Overview
  • 2. Clinical Trials Market Overview (continued)
  • 3. Clinical Trials Scenario
  • 4. Profiles of Clinical Trials
  • 5. CRO Market Segmentation by Stage of Clinical Development

Forecasts and Trends-Total CRO Market

  • 1. Forecast Assumptions
  • 2. Measurements
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Phase I and Phase II Segments-Revenue Forecast
  • 6. Phase III and Phase IV Segments-Revenue Forecast
  • 7. Preclinical Segment-Revenue Forecast
  • 8. Preclinical Segment Revenue Forecast Discussion
  • 9. Data Management Segment-Revenue Forecast
  • 10. Data Management Segment Revenue Forecast Discussion
  • 11. Biostatistics Segment-Revenue Forecast
  • 12. Biostatistics Segment Revenue Forecast Discussion
  • 13. Central Laboratory Services Segment-Revenue Forecast
  • 14. Central Laboratory Services Segment Revenue Forecast Discussion
  • 15. Pharmacovigilance Segment-Revenue Forecast
  • 16. Pharmacovigilance Segment Revenue Forecast Discussion
  • 17. Bioanalytics Segment-Revenue Forecast
  • 18. Bioanalytics Segment Revenue Forecast Discussion
  • 19. HEOR Segment-Revenue Forecast
  • 20. HEOR Segment Revenue Forecast Discussion
  • 21. CRO Market-Key Trends

Regulatory Environment

  • 1. Clinical Research Regulatory Overview
  • 2. Clinical Research Regulatory Overview (continued)
  • 3. Clinical Research Regulatory Process

Competitive Environment

  • 1. Competitive Structure
  • 2. Competitive Analysis-Selected Key Market Participants
  • 3. Competitive Analysis-Selected Key Market Participants (continued)
  • 4. Competitive Analysis-Selected Key Market Participants (continued)
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)

The Last Word

  • 1. The Last Word-Discussion
  • 2. Legal Disclaimer

Appendix

  • 1. List of Exhibits
  • 2. List of Exhibits (continued)

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top